Novonesis (Novozymes) B (NVZMF)
Market Closed
14 Oct, 08:00 PM
$
65. 35
+1.36
+2.1253%
$
27.97B Market Cap
59.14 P/E Ratio
3.42% Div Yield
100 Volume
0 Eps
$ 63.99
Previous Close Want to track NVZMF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novonesis (Novozymes) B (NVZMF) Statistics
Valuation metrics
Market Cap 27.97B
Enterprise value 29.9B
Trailing P/E (ttm) 41.58
Forward P/E -
PEG ratio 1.74
Price/Sales (ttm) 6.31
Price/Book (mrq) 2.43
Enterprise Value/Revenue 6.96
Enterprise Value/EBITDA 23.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 275
Average volume (90 days) 575
Price summary
52-Week low 52.1
52-Week high 72.98
Beta -
50-Day moving average 67.04
200-Day moving average 62.41
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.88
Trailing annual dividend yield 0.0152%
5-Year annual dividend yield -
Payout ratio 0.64
Dividend Date 26 Mar 2026
Ex-Dividend Date 23 Mar 2026
Last split factor 5:1
Last split Date 28 Nov 2011
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.15%
Operating margin 0.21%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.06%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 9.22
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.67
Total debt (mrq) -
Total Debt/Equity (mrq) 0.28
Current ratio (mrq) 1.74%
Book value per share (mrq) 23.93
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
